This invention relates to novel triazole derivatives, which are found to be modulators of the nicotinic acetylcholine receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
                            这项发明涉及新型三唑衍
生物,发现它们是
尼古丁型
乙酰胆碱受体的调节剂。由于其药理特性,本发明的化合物可能对治疗与中枢神经系统(CNS)的
胆碱系统、外周神经系统(
PNS)、平滑肌收缩有关的疾病或紊乱,内分泌疾病或紊乱,神经退行性疾病或紊乱,炎症相关的疾病或紊乱,疼痛以及由于滥用
化学物质终止而引起的戒断症状等多种疾病或紊乱具有用处。